Feb 19, 2026 04:01PM
Jan 16, 2026 01:20PM
Jan 14, 2026 06:48AM
Jan 13, 2026 01:24PM
Jan 13, 2026 01:24PM
Jan 13, 2026 07:27AM
Jan 13, 2026 04:57AM Stifel on Travere Therapeutics (TVTX): 'FSGS Increases Risk of CRL, Though Delay/Approval Still Possible'
Jan 12, 2026 05:00PM
Jan 12, 2026 05:00PM
Dec 24, 2025 11:54AM
Nov 6, 2025 11:00AM
Nov 6, 2025 11:00AM
Oct 30, 2025 04:01PM
Oct 17, 2025 09:01AM Travere Therapeutics to Present Abstracts at American Society of Nephrology (ASN) Kidney Week 2025
Sep 26, 2025 07:02AM
Sep 26, 2025 07:00AM
Sep 11, 2025 06:48AM
Sep 10, 2025 10:30AM
Sep 10, 2025 10:11AM
Sep 10, 2025 09:58AM
Sep 10, 2025 07:01AM FDA cancels advisory committee for Travere's FILSPARI in rare kidney disease
Sep 10, 2025 07:01AM
Sep 3, 2025 07:01AM
Aug 28, 2025 07:33AM
Aug 27, 2025 05:09PM
Aug 27, 2025 05:09PM
Aug 6, 2025 04:01PM
Jul 6, 2025 10:00AM INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Travere Therapeutics, Inc.  - TVTX
Jul 1, 2025 10:00AM
Jun 28, 2025 10:00AM
Jun 23, 2025 11:55AM
Jun 18, 2025 12:13PM
Jun 15, 2025 10:00AM
Jun 11, 2025 07:01AM
Jun 11, 2025 04:58AM Travere Therapeutics (TVTX) PT Lowered to $32 at Citi, Adds 90d Upside Catalyst Watch
Jun 10, 2025 09:00AM
Jun 10, 2025 07:00AM
Jun 6, 2025 11:44AM
Jun 3, 2025 04:30PM
Jun 2, 2025 01:30PM
May 28, 2025 09:00AM
May 22, 2025 09:00AM INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Travere Therapeutics, Inc.  - TVTX
May 22, 2025 09:00AM
May 16, 2025 06:37AM
May 16, 2025 04:20AM
May 15, 2025 04:22PM
May 15, 2025 04:05PM
May 1, 2025 04:01PM
Apr 29, 2025 07:07AM Travere Therapeutics (TVTX) and CSL Vifor Announce Standard EU Approval of FILSPARI (sparsentan) for IgA Nephropathy
Apr 29, 2025 07:01AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All